This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove oncology news
article thumbnail

Drug Channels News Roundup, April 2024: CVS’s Humira Strategy, White Bagging “Savings,” IRA vs. Part D Plans, Walgreens Specialty Update, Pharmacies vs. GoodRx, and Oncology Fun

Drug Channels

APRIL 29, 2024

April is over, so it's time to hop into this month’s selection of noteworthy news: CVS Health’s formulary boosts a Humira biosimilar An insurer ditches buy-and-bill to save money for plans—but maybe not for patients? P.S. Join my nearly 55,000 LinkedIn followers for daily links to neat stuff. All rights reserved.

Specialty Pharmacies 79
Specialty Pharmacies Biosimilars 79
article thumbnail

STAT+: What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise

STAT

JANUARY 25, 2024

Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

279
279
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioMarin appeases an activist

STAT

DECEMBER 21, 2023

Damian here with news of an averted activist challenge, biotech on late-night TV, and the latest deal in oncology’s hottest space. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Read the rest…

Drug Pricing 246
Drug Pricing Drug Development 246
article thumbnail

Listen: Lilly’s obesity drug, the power of radiation, & a biotech implosion

STAT

NOVEMBER 9, 2023

As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. Read the rest…

283
283
article thumbnail

STAT+: Second U.S. oncology provider plans to go public

STAT

OCTOBER 10, 2022

is about to have not just one, but two, standalone publicly-traded oncology providers. Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public. The news comes about a year after another large oncology provider chain hit the stock market.

251
251
article thumbnail

Flagship Pioneering, Metaphore Biotechnologies Strike Deal with Novo Nordisk to Develop High-End Obesity Treatments

PharmExec

MAY 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
52
article thumbnail

Michael Jordan and Novant Health Open New Facility in Basketball Player’s Hometown

PharmExec

MAY 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 33,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024